Carregant...
Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: a compromise between the risk of recurrence and the risk of rejection?
Hepatocellular carcinoma (HCC) recurrence rate after liver transplantation (LT) is still up to 15–20%, despite a careful selection of candidates and optimization of the management within the waiting list. To reduce tumour recurrence, the currently adopted post-transplant strategies are based on the...
Guardat en:
| Publicat a: | Transl Gastroenterol Hepatol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5639004/ https://ncbi.nlm.nih.gov/pubmed/29034347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2017.08.07 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|